SCHEMBL6153057

SCHEMBL6153057

COC(=O)C(=Cc1c(Cl)cccc1Cl)C(=O)CCc1ccccc1CO[Si](C)(C)C(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.40
PLAAT3 P53816 1/20 0.34
PLAAT5 Q96KN8 1/20 0.34
PLAAT2 Q9NWW9 1/20 0.34
PLAAT4 Q9UL19 1/20 0.34
HPGD P15428 3/20 0.32
GLA P06280 1/20 0.32
KMT2A Q03164 5/20 0.32
LMNA P02545 2/20 0.32
HTT P42858 1/20 0.32
MEN1 O00255 2/20 0.31
TSHR P16473 1/20 0.31
ALDH1A1 P00352 1/20 0.31
SLC16A3 O15427 1/20 0.31
SLC16A1 P53985 1/20 0.31
MCTS1 Q9ULC4 1/20 0.31
NPC1 O15118 1/20 0.31
SCN9A Q15858 1/20 0.31
MAPT P10636 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6153056 1.00 BACE1 (0.40) BACE1PLAAT3PLAAT5PLAAT2PLAAT4
SCHEMBL6161539 0.81 PLAAT3 (0.37) PLAAT3PLAAT5PLAAT2PLAAT4HPGD
SCHEMBL6161533 0.81 PLAAT3 (0.37) PLAAT3PLAAT5PLAAT2PLAAT4HPGD
SCHEMBL6153618 0.77 CDYL (0.39) LMNAHTTTSHRALDH1A1
SCHEMBL7247982 0.77 NPSR1 (0.34) PLAAT3PLAAT5PLAAT2PLAAT4HTT
SCHEMBL7247987 0.77 NPSR1 (0.34) PLAAT3PLAAT5PLAAT2PLAAT4HTT
SCHEMBL6153271 0.77 PLAAT3 (0.34) PLAAT3PLAAT5PLAAT2PLAAT4HPGD
SCHEMBL6152947 0.77 PLAAT3 (0.34) PLAAT3PLAAT5PLAAT2PLAAT4HPGD
SCHEMBL7836234 0.76 MEN1 (0.45) PLAAT3PLAAT5PLAAT2PLAAT4HPGD
SCHEMBL7836232 0.76 MEN1 (0.45) PLAAT3PLAAT5PLAAT2PLAAT4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1307449-B1 1,4-DIHYDROPYRIDINES AS BRADYKININ ANTAGONISTS PFIZER PHARMA (JP) 2005-12-07 EP disclosed
US-6653313-B2 For treatment and prevention of inflammation, asthma, allergic rhinitis, pain and other disorders WARNER-LAMBERT COMPANY LLC 2003-11-25 US disclosed
US-20020161006-A1 1,4-dihydropyridine compounds as bradykinin antagonists KAWAMURA MITSUHIRO (US) 2002-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020161006-A1 1,4-dihydropyridine compounds as bradykinin antagonists BDKRB1, BDKRB2, HRH4 BACE1 2048/4885PLAAT3 3652/4885PLAAT5 3156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.